• Markets
    • icon
  • Companies
CLV · ASX

Clover Corporation Limited (ASX:CLV)

AU$0.88

 0.0 (0.0%)
ASX:Live
06/12/2023 04:10:05 PM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CLV Overview

CLV Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About CLV

Website

Clover Corporation Limited

Telephone

61.3.8347.5000

Address

39 Pinnacle Road Altona North, Victoria (VIC) 3025

Description

Clover Corp. Ltd. engages in research and product development of functional food and infant nutrition ingredients. It also focuses on the sale of natural oils and production of encapsulated powders. Its products include Docosahexaenoic acid oils and powders, and Microencapsulation. The company was founded by Guy Hamish Drummond in 1988 and is headquartered in Sydney, Australia.

CLV Price Chart

Key Stats

Market Cap

AU$145.29M

PE

34.20

EV/EBITDA

20.4

Dividends Overview

DIV Yield

1.0%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.7 - 1.47

Trade Value (12mth)

AU$11,223.00

1 week

6.02%

1 month

2.92%

YTD

-27.87%

1 year

-29.32%

All time high

3.31

Key Fundamentals

EPS 3 yr Growth

-50.500%

EBITDA Margin

13.60%

Operating Cashflow

$7m

Free Cash Flow Return

9.00%

ROIC

8.30%

Interest Coverage

14.90

Quick Ratio

2.80

Other Data

Shares on Issue (Fully Dilluted)

167m

HALO Sector

Healthcare

Next Company Report Date

20-Sep-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CLV Announcements

Latest Announcements

Date Announcements

31 October 19

Clover Corporation - Select Equities presentation

×

Clover Corporation - Select Equities presentation

31 October 08

Annual Report/Notice of Annual General Meeting

×

Annual Report/Notice of Annual General Meeting

30 October 13

2013 Annual Report

×

2013 Annual Report

30 October 07

Annual Report/Notice of Annual General Meeting

×

Annual Report/Notice of Annual General Meeting

30 November 12

2012 AGM - Chairman\'s Address and MD Presentation

×

2012 AGM - Chairman\'s Address and MD Presentation

29 September 08

Annual Report to shareholders

×

Annual Report to shareholders

29 October 14

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 October 12

Annual Report / Notice of Annual General Meeting

×

Annual Report / Notice of Annual General Meeting

29 November 22

Notification regarding unquoted securities - CLV

×

Notification regarding unquoted securities - CLV

29 November 13

2013 AGM - Chariman\'s Address and MD Presentation

×

2013 AGM - Chariman\'s Address and MD Presentation

28 October 21

Clover Corporation Select Equities Presentation 28 Oct 21

×

Clover Corporation Select Equities Presentation 28 Oct 21

28 November 22

Change of Director's Interest Notice

×

Change of Director's Interest Notice

28 November 14

2014 AGM - Chairman's Address and CEO Presentation

×

2014 AGM - Chairman's Address and CEO Presentation

28 November 06

MD'S Presentation 2006 AGM

×

MD'S Presentation 2006 AGM

28 April 22

Payment of FY22 Interim Dividend

×

Payment of FY22 Interim Dividend

27 September 10

Amendment to 2010 Annual Report

×

Amendment to 2010 Annual Report

27 October 22

Clover's Premneo improves IQ of children

×

Clover's Premneo improves IQ of children

27 October 11

Annual Report to shareholders

×

Annual Report to shareholders

27 November 23

Notification regarding unquoted securities - CLV

×

Notification regarding unquoted securities - CLV

27 November 23

Notification of cessation of securities - CLV

×

Notification of cessation of securities - CLV

27 November 23

Change of Director's Interest Notice - Appendix 3Y

×

Change of Director's Interest Notice - Appendix 3Y

27 November 17

Results of 2017 Annual General Meeting

×

Results of 2017 Annual General Meeting

27 November 15

2015 AGM - Chairman's Address and CEO Presentation

×

2015 AGM - Chairman's Address and CEO Presentation

27 April 23

Payment of FY23 Interim Dividend

×

Payment of FY23 Interim Dividend

26 September 23

Clover 2023 Appendix 4E

×

Clover 2023 Appendix 4E

26 September 23

Clover 2023 Full Year Results Market Announcement

×

Clover 2023 Full Year Results Market Announcement

26 September 23

Clover 2023 Annual Report

×

Clover 2023 Annual Report

CLV Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.04 0.04 0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.04 0.04 0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -51.9 18.8 -13.3 Lock Lock Lock
     PE X Lock Lock Lock Lock 33.6 29.8 34.2 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 21.8 18.5 20.4 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.05 0.04 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.5 15.5 -13.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.5 1.9 1.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.02 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -60.0 50.0 0.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.1 1.1 1.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 28 35 40 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.35 0.38 0.40 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.34 0.37 0.39 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.4 8.2 6.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 166 166 167 Lock Lock Lock
Basic m Lock Lock Lock Lock 166 166 167 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 61 71 80 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.5 16.8 13.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 9 10 14 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 18 22 24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.6 18.1 10.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 30.1 30.5 29.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 70 70 70 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 10 12 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.3 15.7 -8.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 16.9 16.7 13.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 10 11 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.2 16.8 -10.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.7 15.7 12.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 9 10 9 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 2 3 2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 6 7 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -51.9 18.8 -13.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.9 10.1 7.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 8 7 7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -2 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -7 -4 -5 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 6 5 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.8 -22.1 2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 13 13 13 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 9 10 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 79 91 86 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 12 10 10 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 5 2 2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 20 28 19 Lock Lock Lock
Equity $m Lock Lock Lock Lock 58 63 67 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 71 73 77 Lock Lock Lock
     Growth % Lock Lock Lock Lock 0.6 3.5 4.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 7.6 7.9 7.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 10.3 11.3 9.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 13.2 15.1 12.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 8.5 9.9 8.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 11.6 9.1 9.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 25.4 26.0 14.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.2 0.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 8.7 3.1 3.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.0 3.9 7.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.1 1.8 2.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 16.6 15.1 15.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 105.0 38.2 81.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.0 4.2 5.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.3 1.5 1.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.3 1.4 1.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 8.1 12.8 5.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.9 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.9 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 14.8 14.8 11.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 11.4 11.6 10.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 24.3 25.8 24.4 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 7.6 7.9 7.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.4 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 10.3 11.3 9.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 72.3 65.0 59.7 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 7.4 7.4 5.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 270.8 247.9 236.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 91.9 85.9 72.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 362.7 333.8 308.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 49.8 46.9 41.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 312.9 286.9 267.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

1.0%

Franking Level

100%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CLV Shortsell

Frequently Asked Questions

The current share price of Clover Corporation Limited (CLV:ASX) is AU$0.88.
The 52-week high share price for Clover Corporation Limited (CLV:ASX) is AU$1.47.
The 52-week low share price for Clover Corporation Limited (CLV:ASX)? is AU$0.70.
The current TTM dividend payout for Clover Corporation Limited (CLV:ASX) is 1.00.
The last dividend payment of Clover Corporation Limited (CLV:ASX) is AU$0.01.
Clover Corporation Limited (CLV:ASX) has a franking level of 100%.
Clover Corporation Limited (CLV:ASX) is classified in the Healthcare.
The current P/E ratio for Clover Corporation Limited (CLV:ASX) is 34.20.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.